Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The company returns high margins, thereby supporting business profitability.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Analyst opinion has improved significantly over the past four months.


Weaknesses

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● One of the major weak points of the company is its financial situation.

● The firm trades with high earnings multiples: 23.74 times its 2023 earnings per share.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

● The company's earnings releases usually do not meet expectations.